Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors.

Published on Jun 6, 2018in Contrast Media & Molecular Imaging1.872
· DOI :10.1155/2018/6930425
Anzhelika Vorobyeva11
Estimated H-index: 11
(Uppsala University),
Olga Bragina4
Estimated H-index: 4
(RAS: Russian Academy of Sciences)
+ 7 AuthorsSergey M. Deyev29
Estimated H-index: 29
(Tomsk Polytechnic University)
Sources
Abstract
High expression of human epidermal growth factor receptor 2 (HER2) in breast and gastroesophageal carcinomas is a predictive biomarker for treatment using HER2-targeted therapeutics (antibodies trastuzumab and pertuzumab, antibody-drug conjugate trastuzumab DM1, and tyrosine kinase inhibitor lapatinib). Radionuclide molecular imaging of HER2 expression might permit stratification of patients for HER2-targeting therapies. In this study, we evaluated a new HER2-imaging probe based on the designed ankyrin repeat protein (DARPin) 9_29. DARPin 9_29 was labeled with iodine-125 by direct radioiodination and with [99mTc]Tc(CO)3 using the C-terminal hexahistidine tag. DARPin 9_29 preserved high specificity and affinity of binding to HER2-expressing cells after labeling. Uptake of [125I]I-DARPin 9_29 and [99mTc]Tc(CO)3-DARPin 9_29 in HER2-positive SKOV-3 xenografts in mice at 6 h after injection was 3.4 ± 0.7 %ID/g and 2.9 ± 0.7 %ID/g, respectively. This was significantly () higher than the uptake of the same probes in HER2-negative Ramos lymphoma xenografts, 0.22 ± 0.09 %ID/g and 0.30 ± 0.05 %ID/g, respectively. Retention of [125I]I-DARPin 9_29 in the lung, liver, spleen, and kidneys was appreciably lower compared with [99mTc]Tc(CO)3-DARPin 9_29, which resulted in significantly () higher tumor-to-organ ratios. The biodistribution data were confirmed by SPECT/CT imaging. In conclusion, radioiodine is a preferable label for DARPin 9_29.
Figures & Tables
Download
📖 Papers frequently viewed together
53 Citations
59 Citations
17 Citations
References46
Newest
#1Ahmet KrasniqiH-Index: 8
Last. Vladimir Tolmachev (Uppsala University)H-Index: 61
view all 8 authors...
Imaging of expression of therapeutic targets may enable patients' stratification for targeted treatments. The use of small radiolabeled probes based on the heavy-chain variable region of heavy-chai ...
59 CitationsSource
#1Rudo Simeon (A&M: Texas A&M University)H-Index: 7
#2Zhilei Chen (A&M: Texas A&M University)H-Index: 17
Antibodies have proved to be a valuable mode of therapy for numerous diseases, mainly owing to their high target binding affinity and specificity. Unfortunately, antibodies are also limited in several respects, chief amongst those being the extremely high cost of manufacture. Therefore, non-antibody binding proteins have long been sought after as alternative therapies. New binding protein scaffolds are constantly being designed or discovered with some already approved for human use by the FDA. T...
84 CitationsSource
#1Dominik SummerH-Index: 10
#2Javad Garousi (Uppsala University)H-Index: 13
Last. Clemens DecristoforoH-Index: 53
view all 10 authors...
Zirconium-89 is an emerging radionuclide for positron emission tomography (PET) especially for biomolecules with slow e pharmacokinetics as due to its longer half-life, in comparison to fluorine 18 ...
24 CitationsSource
#1Sarah Lindbo (KTH: Royal Institute of Technology)H-Index: 8
#2Javad Garousi (Uppsala University)H-Index: 13
Last. Vladimir Tolmachev (Uppsala University)H-Index: 61
view all 8 authors...
Visualization of cancer-associated alterations of molecular phenotype using radionuclide imaging is a noninvasive approach to stratifying patients for targeted therapies. The engineered albumin-bin ...
27 CitationsSource
#1Dan Sandberg (Uppsala University)H-Index: 6
#2Vladimir Tolmachev (Uppsala University)H-Index: 61
Last. Jens Nørkær Sørensen (Uppsala University)H-Index: 66
view all 9 authors...
Purpose In phase I/II-studies radiolabelled ABY-025 Affibody molecules identified human epidermal growth factor receptor 2 (HER2) expression in breast cancer metastases using PET and SPECT imaging. Here, we wanted to investigate the utility of a simple intra-image normalization using tumour-to-reference tissue-ratio (T/R) as a HER2 status discrimination strategy to overcome potential issues related to cross-calibration of scanning devices.
25 CitationsSource
#1Javad Garousi (Uppsala University)H-Index: 13
#2Hadis Honarvar (Uppsala University)H-Index: 17
Last. Vladimir Tolmachev (Uppsala University)H-Index: 61
view all 9 authors...
Overexpression of the enzyme carbonic anhydrase IX (CAIX) is documented for chronically hypoxic malignant tumors as well as for normoxic renal cell carcinoma. Radionuclide molecular imaging of CAIX would be useful for detection of hypoxic areas in malignant tumors, for patients’ stratification for CAIX-targeted therapies, and for discrimination of primary malignant and benign renal tumors. Earlier, we have reported feasibility of in vivo radionuclide based imaging of CAIX expressing tumors using...
20 CitationsSource
#1E. A. Sokolova (RAS: Russian Academy of Sciences)H-Index: 8
#2G. M. Proshkina (RAS: Russian Academy of Sciences)H-Index: 11
Last. Sergey M. Deyev (RAS: Russian Academy of Sciences)H-Index: 29
view all 10 authors...
Abstract DARPins fused with other proteins are promising non-immunoglobulin scaffolds for specific binding to target cells. In this study HER2-specific DARPin (DARPin_9–29) was used as a tumor-targeting moiety for the delivery of a cytotoxic agent – the fragment of Pseudomonas aeruginosa exotoxin A. It was determined that DARPin-PE40 possesses a considerable cytotoxic activity and induces apoptosis in HER2-positive cells. Cytotoxic effect of DARPin-PE40 strongly correlates with the HER2 expressi...
33 CitationsSource
#1Sarah Lindbo (KTH: Royal Institute of Technology)H-Index: 8
#2Javad GarousiH-Index: 13
Last. Vladimir TolmachevH-Index: 61
view all 7 authors...
Engineered scaffold proteins (ESP) are high-affinity binders that can be used as probes for radionuclide imaging. Histidine-containing tags enable both efficient purification of ESP and radiolabeling with 99mTc(CO)3. Earlier studies demonstrated that the use of a histidine-glutamate-histidine-glutamate-histidine-glutamate (HE)3-tag instead of the commonly used hexahistidine (H6)-tag reduces hepatic uptake of radiolabeled ESP and short peptides. Here, we investigated the influence of histidine-co...
25 CitationsSource
#1Jens Nørkær Sørensen (Uppsala University)H-Index: 66
#2Irina Velikyan (Uppsala University)H-Index: 22
Last. Henrik LindmanH-Index: 25
view all 12 authors...
PURPOSE: Positron Emission Tomography (PET) imaging of HER2 expression could potentially be used to select patients for HER2-targed therapy, predict response based on uptake and be used for monitor ...
120 CitationsSource
#1Rodrigo Vazquez-Lombardi (UNSW: University of New South Wales)H-Index: 8
#2Tri Giang Phan (UNSW: University of New South Wales)H-Index: 39
Last. Daniel Christ (UNSW: University of New South Wales)H-Index: 26
view all 6 authors...
The first candidates from the promising class of small non-antibody protein scaffolds are now moving into clinical development and practice. Challenges remain, and scaffolds will need to be further tailored toward applications where they provide real advantages over established therapeutics to succeed in a rapidly evolving drug development landscape.
142 CitationsSource
Cited By23
Newest
#1Tianqi Xu (Uppsala University)H-Index: 2
#2Anzhelika Vorobyeva (Uppsala University)H-Index: 11
Last. Vladimir Tolmachev (Uppsala University)H-Index: 61
view all 11 authors...
Efficient treatment of disseminated ovarian cancer (OC) is challenging due to its heterogeneity and chemoresistance. Overexpression of human epidermal growth factor receptor 2 (HER2) and epithelial cell adhesion molecule (EpCAM) in approx. 30% and 70% of ovarian cancers, respectively, allows for co-targeted treatment. The clinical efficacy of the monoclonal antibody trastuzumab in patients with HER2-positive breast, gastric and gastroesophageal cancers makes it readily available as the HER2-targ...
1 CitationsSource
#1Vladimir Tolmachev (Tomsk Polytechnic University)H-Index: 61
#2Anna Orlova (Tomsk Polytechnic University)H-Index: 53
Last. Jens Nørkær Sørensen (Uppsala University)H-Index: 66
view all 3 authors...
Abstract Targeting of human epidermal growth factor type 2 (HER2) using monoclonal antibodies, antibody-drug conjugates and tyrosine kinase inhibitors extends survival of patients with HER2-expressing metastatic breast cancer. High expression of HER2 is a predictive biomarker for such specific treatment. Accurate determination of HER2 expression level is necessary for stratification of patients to targeted therapy. Non-invasive in vivo radionuclide molecular imaging of HER2 has a potential of re...
1 CitationsSource
#1Khurram Shahzad (H.I., S.I.: University of Agriculture, Faisalabad)H-Index: 5
#2Aman Shah Abdul Majid (International University, Cambodia)H-Index: 17
Last. Asjad Ali (H.I., S.I.: University of Agriculture, Faisalabad)
view all 5 authors...
Source
Abstract Recent progress in radiolabeling of macro- and middle-sized molecular probes has been extending possibilities to use PET molecular imaging for dynamic application to drug development and therapeutic evaluation. Theranostics concept also accelerated the use of macro- and middle-sized molecular probes for sharpening the contrast of proper target recognition even the cellular types/subtypes and proper selection of the patients who should be treated by the same molecules recognition. Here, ...
4 CitationsSource
#1V. Chernov (Research Medical Center)H-Index: 2
#2A. Medvedeva (Research Medical Center)H-Index: 2
view all 6 authors...
Source
#1Anzhelika Vorobyeva (Uppsala University)H-Index: 11
#2Ekaterina Bezverkhniaia (Tomsk Polytechnic University)H-Index: 1
Last. Vladimir Tolmachev (Uppsala University)H-Index: 61
view all 10 authors...
Efficient treatment of disseminated triple-negative breast cancer (TNBC) remains an unmet clinical need. The epithelial cell adhesion molecule (EpCAM) is often overexpressed on the surface of TNBC cells, which makes EpCAM a potential therapeutic target. Radionuclide molecular imaging of EpCAM expression might permit selection of patients for EpCAM-targeting therapies. In this study, we evaluated a scaffold protein, designed ankyrin repeat protein (DARPin) Ec1, for imaging of EpCAM in TNBC. DARPi...
4 CitationsSource
#1Anzhelika VorobyevaH-Index: 11
#2Maryam OroujeniH-Index: 7
Last. Javad GarousiH-Index: 13
view all 8 authors...
Albumin binding domain-Derived Affinity ProTeins (ADAPTs) are small (5 kDa) engineered scaffold proteins that are promising targeting agents for radionuclide-based imaging. A recent clinical study has demonstrated that radiolabeled ADAPTs can efficiently visualize human epidermal growth factor receptor 2 (HER2) expression in breast cancer using SPECT imaging. However, the use of ADAPTs directly labeled with radiometals for targeted radionuclide therapy is limited by their high reabsorption and p...
1 CitationsSource
The object of the study was to analyze radionuclide detection techniques for in vivo animal imaging. Material and Methods. A total of 49 publications available from Scopus, Web of Science, Google Scholar eLIBRARY and Pubmed and published between 2013 and 2019 were reviewed. Results. The nuclear medicine techniques, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) are the most suitable imaging modalities for in vivo animal imaging. Besides traditio...
Source
#1Javad Garousi (Uppsala University)H-Index: 13
#2Anna Orlova (Tomsk Polytechnic University)H-Index: 53
Last. Vladimir Tolmachev (Tomsk Polytechnic University)H-Index: 61
view all 4 authors...
The use of radiolabelled antibodies was proposed in 1970s for staging of malignant tumours. Intensive research established chemistry for radiolabelling of proteins and understanding of factors determining biodistribution and targeting properties. The use of radioimmunodetection for staging of cancer was not established as common practice due to approval and widespread use of [18F]-FDG, which provided a more general diagnostic use than antibodies or their fragments. Expanded application of antibo...
8 CitationsSource
#1Anzhelika Vorobyeva (Uppsala University)H-Index: 11
#2Elena Konovalova (RAS: Russian Academy of Sciences)H-Index: 5
Last. Sergey Deyev (Tomsk Polytechnic University)H-Index: 2
view all 10 authors...
Epithelial cell adhesion molecule (EpCAM) is overexpressed in 55%–75% of ovarian carcinomas (OC). EpCAM might be used as a target for a treatment of disseminated OC. Designed ankyrin repeats protein (DARPin) Ec1 is a small (18 kDa) protein, which binds to EpCAM with subnanomolar affinity. We tested a hypothesis that Ec1 labeled with a non-residualizing label might serve as a companion imaging diagnostic for stratification of patients for EpCAM-targeting therapy. Ec1 was labeled with 125I using N...
5 CitationsSource